Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Banca Mediolanum SpA (BMED)
Banca Mediolanum SpA stock price live, this page displays BIT BMED stock exchange data. View the BMED premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Banca Mediolanum SpA real time stock price chart below.
What Is the Banca Mediolanum SpA Stock Price Today?
The Banca Mediolanum SpA stock price today is 19.840.
What Is the Stock Symbol for Banca Mediolanum SpA?
The stock symbol for Banca Mediolanum SpA is "BMED."
What Stock Exchange Does Banca Mediolanum SpA Trade On?
Banca Mediolanum SpA is listed and trades on the Milan stock exchange.
Is Banca Mediolanum SpA a Good Stock to Buy?
Determining whether Banca Mediolanum SpA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BMED quote. (ISIN: IT0004776628)
What Is the Banca Mediolanum SpA Stock Price Today?
The Banca Mediolanum SpA stock price today is 19.840.
What Is the Stock Symbol for Banca Mediolanum SpA?
The stock symbol for Banca Mediolanum SpA is "BMED."
What Stock Exchange Does Banca Mediolanum SpA Trade On?
Banca Mediolanum SpA is listed and trades on the Milan stock exchange.
Is Banca Mediolanum SpA a Good Stock to Buy?
Determining whether Banca Mediolanum SpA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BMED quote. (ISIN: IT0004776628)
19.840
+0.360(+1.85%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.570
20.060
52 wk Range
11.470
20.200
Earnings results expected in 7 days
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.57020.060
52 wk Range
11.47020.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(6.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(6.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BMED Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
20.691
Upside
+4.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Pays a significant dividend to shareholders
- Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Banca Mediolanum SpA Earnings Call Summary for Q3/2025
- Banca Mediolanum reported Q3 2025 net income of €726 million (+8% YoY), with stock rising 2.29% to €17.45 following the announcement despite a 5% decline in net interest income.
- Net commission income surged 11% to €967 million, offsetting interest income decline and helping drive a 5% increase in both contribution margin (€1.56B) and operating margin (€891M).
- The bank launched a new Intelligent Investment Strategy and reported strong managed asset net inflows, with CEO Massimo Doris expressing confidence in the company's model and strategy.
- Management forecasts double-digit net interest income growth for 2026, targeting €8-8.5B in managed asset inflows, maintaining cost-to-income ratio below 40%, and planning €0.60/share dividend.
- Analysts raised questions about performance fees (estimated at €150M), stable management fee margins, and the company's investment in Spanish operations, which is expected to improve profitability.
Last Updated: 2025-11-06, 01:22 p/m
Read Full TranscriptCompare BMED to Peers and Sector
Metrics to compare | BMED | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipBMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.3x | 10.8x | 10.1x | |
PEG Ratio | 0.46 | 0.56 | 0.03 | |
Price/Book | 3.2x | 1.4x | 1.0x | |
Price / LTM Sales | 5.9x | 4.0x | 2.9x | |
Upside (Analyst Target) | 6.3% | 4.7% | 12.7% | |
Fair Value Upside | Unlock | −9.7% | 1.1% | Unlock |
Analyst Ratings
8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 20.691
(+4.29% Upside)
Earnings
Latest Release
Dec 16, 2025
EPS / Forecast
0.3326 / 0.3219
Revenue / Forecast
532.00M / --
People Also Watch
FAQ
What Is the Banca Mediolanum (BMED) Stock Price Today?
The Banca Mediolanum stock price today is 19.840
What Stock Exchange Does Banca Mediolanum Trade On?
Banca Mediolanum is listed and trades on the Milan Stock Exchange stock exchange.
What Is the Stock Symbol for Banca Mediolanum?
The stock symbol for Banca Mediolanum is "BMED."
Does Banca Mediolanum Pay Dividends? What’s The Current Dividend Yield?
The Banca Mediolanum dividend yield is 6.31%.
What Is the Banca Mediolanum Market Cap?
As of today, Banca Mediolanum market cap is 14.68B.
What Is Banca Mediolanum's Earnings Per Share (TTM)?
The Banca Mediolanum EPS (TTM) is 1.57.
When Is the Next Banca Mediolanum Earnings Date?
Banca Mediolanum will release its next earnings report on Feb 03, 2026.
From a Technical Analysis Perspective, Is BMED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Banca Mediolanum Stock Split?
Banca Mediolanum has split 0 times.
What is the current trading status of Banca Mediolanum (BMED)?
As of Jan 27, 2026, Banca Mediolanum (BMED) is trading at a price of 19.840, with a previous close of 19.480. The stock has fluctuated within a day range of 19.570 to 20.060, while its 52-week range spans from 11.470 to 20.200.
What Is Banca Mediolanum (BMED) Price Target According to Analysts?
The average 12-month price target for Banca Mediolanum is EUR20.691, with a high estimate of EUR22 and a low estimate of EUR18.9. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +4.29% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.